Quick Answer
Atea Pharmaceuticals, Inc. reported Net Income of -$158.35 million for fiscal year 2025.
Atea Pharmaceuticals, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$158.35M | +6.0% |
| 2024 | -$168.38M | -23.9% |
| 2023 | -$135.96M | -17.3% |
| 2022 | -$115.91M | -195.6% |
| 2021 | $121.19M | +1207.1% |
| 2020 | -$10.95M | +22.0% |
| 2019 | -$14.03M | -54.8% |
| 2018 | -$9.06M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$42.05M | -35.0% | -13.2% |
| June 30, 2025 | -$37.16M | +8.3% | -8.4% |
| March 31, 2025 | -$34.27M | +45.7% | -10.0% |
| September 30, 2024 | -$31.15M | +6.0% | +23.1% |
| June 30, 2024 | -$40.52M | -43.8% | +35.9% |
| March 31, 2024 | -$63.17M | -78.1% | -90.6% |
| September 30, 2023 | -$33.14M | -310.9% | -17.6% |
| June 30, 2023 | -$28.18M | +10.1% | +20.5% |
- Atea Pharmaceuticals, Inc. showed an increase of +6.0% in Net Income compared to the prior fiscal year.
- Over the 2018–2025 period, Atea Pharmaceuticals, Inc.’s net income has declined by 1647.0% (from -$9.06 million to -$158.35 million).
- The most recent figure is from Atea Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: